Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -41251.75x is 146% below its 5-year average of -16780.00x, near the low end of its 5-year range (-48373.00x–-121.99x).
32.46% below its 12-month average of -31143.61x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -48373.00x.
INTEREST COVERAGE RATIO
-41251.75x
INTEREST COVERAGE RATIO AVG TTM
-31143.61x
INTEREST COVERAGE RATIO AVG 3Y
-23476.11x
INTEREST COVERAGE RATIO AVG 5Y
-16780.00x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-32.46%
CURRENT VS 3Y AVG
-75.72%
CURRENT VS 5Y AVG
-145.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.22x
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
-662578.71%
vs the sector median at left
ProKidney Corp.
Market Cap
$532.96M
Interest Coverage Ratio
-41251.75x
TTM Avg
-31143.61x
3Y Avg
-23476.11x
5Y Avg
-16780.00x
Market Cap
$531.78M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$532.00M
Interest Coverage Ratio
-2.35x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$534.10M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$535.07M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$535.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$536.14M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$523.67M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$518.71M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ProKidney Corp. (PROK) | $532.96M | -41251.75x | -31143.61x | -23476.11x | -16780.00x |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $531.78M | N/A | N/A | N/A | N/A |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $532.00M | -2.35x | N/A | N/A | N/A |
| Shattuck Labs, Inc. (STTK)vs › | $534.10M | N/A | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $535.07M | N/A | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $535.61M | N/A | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $536.14M | N/A | N/A | N/A | N/A |
| Monopar Therapeutics Inc. (MNPR)vs › | $523.67M | N/A | N/A | N/A | N/A |
| Immix Biopharma, Inc. (IMMX)vs › | $518.71M | N/A | N/A | N/A | N/A |
| Altimmune, Inc. (ALT)vs › | $514.38M | -57.76x | N/A | N/A | N/A |
Interest Coverage
-41251.8x
Debt/Equity
N/A
Current Ratio
8.36
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -48373.00x |
| 2026-03-31 | -2995.53x |
| 2025-12-31 | -45371.00x |
| 2025-09-30 | -19269.50x |
| 2025-06-30 | -39709.00x |
| 2024-12-31 | -25785.50x |
| 2024-09-30 | -24486.50x |
| 2024-06-30 | -14352.00x |
| 2024-03-31 | -20038.00x |
| 2023-12-31 | -8070.00x |
| 2023-09-30 | -23308.50x |
| 2023-06-30 | -9954.75x |
| 2023-03-31 | -13625.33x |
| 2022-12-31 | -15117.50x |
| 2022-09-30 | -1226.62x |
| 2022-06-30 | -121.99x |
| 2022-03-31 | -4747.29x |
| 2021-09-30 | -17081.00x |
| 2020-12-31 | -7806.00x |
